NEWSROOM

Biotechnolgy

Easy Environmental Solutions introduces Nano Void technology into 2 new industries with orders for systems for local Minnesota businesses

Easy Environmental Solutions introduces Nano Void technology into 2 new industries with orders for systems for local Minnesota businesses

Expansion into New Industries: Easy Environmental Solutions is installing Nano Void systems at two Minnesota sites—a livestock truck wash and a northern resort—for waste management and lake dredging. Valued at $200,000, these combine oxygenated bubbles and microbial solutions to reduce odors and waste, generating recurring revenue. Advanced Technology Models Ready for Market: After three years of testing, the company offers three Nano Void models (150, 60, 30) for agriculture and water...

read more
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month

NEW YORK, September 25, 2024 - PRISM MediaWire - PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO). In this interview, Dr. Chancellor provides insights into the company's latest advancements in urological treatments, particularly in recognition of Urology Awareness Month, and discusses the significant progress made in the development of therapies for hemorrhagic cystitis (HC)....

read more
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

Melanocortin receptors on neurons in the brain control feeding and weight loss Patented peptide molecules delivered orally as a pill can control feeding disorders and weight loss NEW YORK, NY, August 09, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA) has announced that, as a result of its worldwide licensing agreement with Teleost Biopharmaceuticals and the University of Arizona, it plans to pursue the development of therapeutics using novel proprietary peptides that selectively bind and activate...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850